Cargando…
An mRNA vaccine to prevent genital herpes
The rapid development of two nucleoside-modified mRNA vaccines that are safe and highly effective against coronavirus disease 2019 has transformed the vaccine field. The mRNA technology has the advantage of accelerated immunogen discovery, induction of robust immune responses, and rapid scale up of...
Autores principales: | Awasthi, Sita, Friedman, Harvey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695322/ https://www.ncbi.nlm.nih.gov/pubmed/34954087 http://dx.doi.org/10.1016/j.trsl.2021.12.006 |
Ejemplares similares
-
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
por: Hook, Lauren M., et al.
Publicado: (2022) -
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
por: Awasthi, Sita, et al.
Publicado: (2017) -
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
por: Egan, Kevin P., et al.
Publicado: (2020) -
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
por: Egan, Kevin, et al.
Publicado: (2020) -
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
por: LaTourette, Philip C., et al.
Publicado: (2020)